232 related articles for article (PubMed ID: 14534363)
1. Agonist-dependent internalization of the human melanocortin-4 receptors in human embryonic kidney 293 cells.
Gao Z; Lei D; Welch J; Le K; Lin J; Leng S; Duhl D
J Pharmacol Exp Ther; 2003 Dec; 307(3):870-7. PubMed ID: 14534363
[TBL] [Abstract][Full Text] [Related]
2. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
3. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
Shinyama H; Masuzaki H; Fang H; Flier JS
Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
[TBL] [Abstract][Full Text] [Related]
4. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
[TBL] [Abstract][Full Text] [Related]
5. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of agonist-dependent parathyroid hormone receptor trafficking in whole cells using a functional green fluorescent protein conjugate.
Conway BR; Minor LK; Xu JZ; D'Andrea MR; Ghosh RN; Demarest KT
J Cell Physiol; 2001 Dec; 189(3):341-55. PubMed ID: 11748592
[TBL] [Abstract][Full Text] [Related]
7. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
8. Effects of melanocortin-4 receptor agonists and antagonists on expression of genes related to reproduction in spotted scat, Scatophagus argus.
Jiang DN; Li JT; Tao YX; Chen HP; Deng SP; Zhu CH; Li GL
J Comp Physiol B; 2017 May; 187(4):603-612. PubMed ID: 28197776
[TBL] [Abstract][Full Text] [Related]
9. Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.
Molden BM; Cooney KA; West K; Van Der Ploeg LH; Baldini G
Mol Endocrinol; 2015 Nov; 29(11):1619-33. PubMed ID: 26418335
[TBL] [Abstract][Full Text] [Related]
10. Cell signaling and trafficking of human melanocortin receptors in real time using two-photon fluorescence and confocal laser microscopy: differentiation of agonists and antagonists.
Cai M; Varga EV; Stankova M; Mayorov A; Perry JW; Yamamura HI; Trivedi D; Hruby VJ
Chem Biol Drug Des; 2006 Oct; 68(4):183-93. PubMed ID: 17105482
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
[TBL] [Abstract][Full Text] [Related]
13. Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms.
Xiang Z; Pogozheva ID; Sorenson NB; Wilczynski AM; Holder JR; Litherland SA; Millard WJ; Mosberg HI; Haskell-Luevano C
Biochemistry; 2007 Jul; 46(28):8273-87. PubMed ID: 17590021
[TBL] [Abstract][Full Text] [Related]
14. Ligand-regulated internalization of the opioid receptor-like 1: a confocal study.
Corbani M; Gonindard C; Meunier JC
Endocrinology; 2004 Jun; 145(6):2876-85. PubMed ID: 15016723
[TBL] [Abstract][Full Text] [Related]
15. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.
Fernandes SM; Lee YS; Gillies RJ; Hruby VJ
Bioorg Med Chem; 2014 Nov; 22(22):6360-5. PubMed ID: 25438759
[TBL] [Abstract][Full Text] [Related]
17. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
18. Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions.
Haskell-Luevano C; Lim S; Yuan W; Cone RD; Hruby VJ
Peptides; 2000 Jan; 21(1):49-57. PubMed ID: 10704719
[TBL] [Abstract][Full Text] [Related]
19. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
20. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
Yang Y; Chen M; Ventro G; Harmon CM
Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
